03.06.2011 • News

Formosa May Move Up Naphtha Cracker Maintenance

Formosa Petrochemical said it may reschedule maintenance at the largest of its three naphtha crackers to second-half August from early September if some downstream units are shut for an extended time following a fire at a pipeline.

"The situation is still unclear because it really depends on the status of the downstream units," a spokesman for the company said on Thursday.

"If the ethylene feedstock cannot be soaked up, we will forward the maintenance of the No. 3 cracker by two weeks." Formosa, Asia's top naphtha buyer, operates three crackers, of which its No. 3 unit has a nameplate capacity of 1.2 million tons per year (tpy) and is operating at 85% capacity.

Its 700,000 tpy No. 1 cracker was taken offline after the fire occurred, and it remains shut with no clear indication when it will restart, said the spokesman. The 1.03 million tpy No. 2 unit is also operating around 85% capacity.

Traders were previously expecting the No. 1 cracker to restart in the second half of June.

"But things are getting increasingly unclear, with traders' opinions being divided," said a North Asian trader.

"The market does not have a clear direction now of where it is going. Some said the market is bottoming out because Formosa is to restart the No. 1 cracker soon. Others disagree and think there will be an extended shutdown."

 

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download
Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

most read